{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:04Z","timestamp":1753891024839,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hypercalcemia is a frequent occurrence in hospitalized patients. It can vary in presentation and severity, and appropriate treatment requires targeting of the underlying condition. Rarer causes of hypercalcemia, such as hyperthyroidism and granulomatous diseases, need to be addressed after excluding the more prevalent etiologies, namely primary hyperparathyroidism and malignancies. We report a case of moderate hypercalcemia in a patient with HIV-positivity with new-onset autoimmune hyperthyroidism as well as concomitant chronic granulomas due to silicone injections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>A 61-year-old patient presented with generalized malaise, asthenia, dyspnea and dysphagia associated with rapid weight loss and recurrent panic attacks. Biochemical work-up revealed moderate hypercalcemia and overt hyperthyroidism with positive anti-TSH-receptor antibodies. Hydration, loop diuretics and methimazole were initiated immediately. Suppressed parathyroid hormone (PTH) levels excluded PTH-mediated hypercalcemia (e.g., primary hyperparathyroidism) and among causes of non-PTH-mediated hypercalcemia, malignancies were excluded. Granulomas secondary to past silicone injections were also found in our patient, however normal 1,25-dihydroxy vitamin D<jats:sub>3<\/jats:sub> levels. Treatment of hyperthyroidism with normalization of thyroid function tests was simultaneously followed by improvement of calcium and PTH levels supporting the diagnosis of hypercalcemia secondary to Graves\u2019 disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Learning points<\/jats:title><jats:p>Hyperthyroidism is a rare cause of hypercalcemia, but it has to be considered in suggestive clinical settings. In our case, prompt management of Graves\u2019 disease contributed to the normalization of calcium levels. This, in turn, supported the differential diagnosis of non-PTH-mediated hypercalcemia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1447652","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:43:36Z","timestamp":1737438216000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-parathyroid hypercalcemia in a patient with new-onset hyperthyroidism and silicone-induced granulomas: case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Laura","family":"Montefusco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iulia","family":"Petria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Fiorina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia","volume":"328","author":"Walker","year":"2022","journal-title":"JAMA"},{"key":"B2","article-title":"A practical approach to hypercalcemia","volume":"67","author":"Carroll","year":"2003","journal-title":"Am Fam Physician"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab504","article-title":"Rare causes of hypercalcemia: 2021 update","volume":"106","author":"Motlaghzadeh","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/0003-4819-65-3-429","article-title":"Hyperscalcemia of thyrotoxicosis","volume":"65","author":"Baxter","year":"1966","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-238898","article-title":"Severe hypercalcaemia secondary to relapsed Graves\u2019 disease","volume":"14","author":"Khan","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006017","article-title":"Hyperthyroidism-associated hypercalcemic crisis","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35206","article-title":"Rare presentation of a common disease: graves\u2019 Thyrotoxicosis presented with non-parathyroid hypercalcemia and jaundice","volume":"15","author":"Ajwah","year":"2023","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221099120","article-title":"An unusual case of hyperthyroidism with recurrent vomiting and hypercalcemia as the main manifestations","volume":"50","author":"Wei","year":"2022","journal-title":"J Int Med Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2012.05.005","article-title":"Mechanisms of action of thyroid hormones in the skeleton","volume":"1830","author":"Wojcicka","year":"2013","journal-title":"Biochim Biophys Acta (BBA) - Gen Subj"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/er.2016-1070","article-title":"Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment","volume":"37","author":"Tebben","year":"2016","journal-title":"Endocr Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-23-0067","article-title":"2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management","volume":"12","author":"Durante","year":"2023","journal-title":"Eur Thyroid J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13516","article-title":"Imaging of cosmetic plastic procedures and implants in the body and their potential complications","volume":"204","author":"Yahyavi-Firouz-Abadi","year":"2015","journal-title":"Am J Roentgenology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/25787489.2020.1836900","article-title":"Causes of hypercalcemia in people living with HIV in the HAART era","volume":"21","author":"Nongnuch","year":"2020","journal-title":"HIV Res Clin Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"k4074","DOI":"10.1136\/bmj.k4074","article-title":"Hypercalcaemia with undetectable parathormone levels","volume":"363","author":"Muller","year":"2018","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2015.122","article-title":"Mechanisms of osteolytic and osteoblastic skeletal lesions","volume":"4","author":"David Roodman","year":"2015","journal-title":"Bonekey Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.3.579","article-title":"Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages","volume":"18","author":"Hewison","year":"2003","journal-title":"J Bone Mineral Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.36518\/2689-0216.1343","article-title":"Free silicone-induced granulomatosis and hypercalcemia in a transgender female","volume":"3","author":"Pando","year":"2022","journal-title":"HCA Healthcare J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.452","article-title":"Silicone induced severe hypercalcemia","volume":"5","author":"K Jayathilaka","year":"2021","journal-title":"J Endocr Soc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac150.338","article-title":"ODP095 HYPERCALCEMIA FROM SILICONE BUTTOCK INJECTION INDUCED GRANULOMA","volume":"6","author":"Chin","year":"2022","journal-title":"J Endocr Soc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.07.002","article-title":"Endocrine disorders with parathyroid hormone-independent hypercalcemia","volume":"50","author":"Simonsen","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2010.02385.x","article-title":"Evaluation of serum parathyroid hormone-related peptide in hyperthyroid patients","volume":"41","author":"Giovanella","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.935821","article-title":"A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia","volume":"28","author":"Tonon","year":"2022","journal-title":"Med Sci Monitor"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0707309","article-title":"Graves\u2019 Disease, thymus enlargement, and hypercalcemia","volume":"358","author":"Giovanella","year":"2008","journal-title":"New Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4137\/CMED.S7116","article-title":"An unusual case of hypercalcemia associated with graves\u2019 Disease and vitamin D deficiency","volume":"4","author":"Korytnaya","year":"2011","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.2605","article-title":"Hypercalcemic crisis due to primary hyperparathyroidism occurring concomitantly with graves\u2019 Disease","volume":"54","author":"Yokomoto","year":"2015","journal-title":"Internal Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1022","article-title":"An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves\u2019 disease","volume":"5","author":"Gupta","year":"2017","journal-title":"Clin Case Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1515\/enr-2016-0024","article-title":"A case of hypercalcaemic crisis secondary to coexistence of primary hyperparathyroidism and Graves\u2019 disease","volume":"50","author":"Baldane","year":"2016","journal-title":"Endocr Regul"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0198","article-title":"Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab","volume":"67","author":"Uchida","year":"2020","journal-title":"Endocr J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4158\/ACCR-2018-0217","article-title":"Co-existence of primary hyperparathyroidism due to multiple endocrine neoplasia 1 in a hypercalcemic patient with graves disease","volume":"5","author":"Bhat","year":"2019","journal-title":"AACE Clin Case Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12902-020-00583-8","article-title":"The coexistence of hypercalcemia, osteoporosis and thymic enlargement in graves\u2019 disease: a case report","volume":"20","author":"Yan","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-251454","article-title":"Hypercalcaemia as the initial presentation of Graves\u2019 disease","volume":"15","author":"Kaur","year":"2022","journal-title":"BMJ Case Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1447652\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:43:38Z","timestamp":1737438218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1447652\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":31,"alternative-id":["10.3389\/fendo.2024.1447652"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1447652","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"article-number":"1447652"}}